Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 6630.77 | 459 / 459 | 100% | 132.15 | 1118 / 1118 |
esophagus | 100% | 6860.72 | 1445 / 1445 | 100% | 108.91 | 183 / 183 |
lung | 100% | 5945.36 | 577 / 578 | 100% | 100.56 | 1155 / 1155 |
ovary | 100% | 9091.34 | 180 / 180 | 100% | 86.04 | 429 / 430 |
brain | 100% | 11844.59 | 2642 / 2642 | 100% | 156.23 | 703 / 705 |
prostate | 100% | 5793.23 | 244 / 245 | 100% | 126.33 | 502 / 502 |
thymus | 100% | 6513.13 | 652 / 653 | 100% | 158.18 | 602 / 605 |
uterus | 100% | 6169.97 | 170 / 170 | 99% | 95.25 | 456 / 459 |
kidney | 100% | 5742.07 | 89 / 89 | 99% | 113.57 | 894 / 901 |
bladder | 100% | 6915.52 | 21 / 21 | 99% | 84.46 | 497 / 504 |
stomach | 100% | 4194.16 | 359 / 359 | 98% | 65.17 | 279 / 286 |
adrenal gland | 100% | 6512.88 | 258 / 258 | 97% | 110.07 | 224 / 230 |
intestine | 100% | 5557.52 | 964 / 966 | 98% | 59.97 | 514 / 527 |
liver | 100% | 3324.09 | 225 / 226 | 95% | 52.01 | 387 / 406 |
skin | 100% | 4873.93 | 1801 / 1809 | 95% | 88.12 | 449 / 472 |
pancreas | 89% | 2021.84 | 291 / 328 | 99% | 83.70 | 176 / 178 |
adipose | 100% | 7158.34 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10467.78 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 7374.77 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 95.61 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 47.49 | 1 / 1 |
spleen | 100% | 3270.12 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 4759.92 | 837 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 57.28 | 70 / 80 |
peripheral blood | 84% | 2395.90 | 777 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 66% | 22.78 | 19 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005769 | Cellular component | early endosome |
GO_0055037 | Cellular component | recycling endosome |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | RNF11 |
Protein name | RING finger protein 11 |
Synonyms | CGI-123 |
Description | FUNCTION: Essential component of a ubiquitin-editing protein complex, comprising also TNFAIP3, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. Promotes the association of TNFAIP3 to RIPK1 after TNF stimulation. TNFAIP3 deubiquitinates 'Lys-63' polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Recruits STAMBP to the E3 ubiquitin-ligase SMURF2 for ubiquitination, leading to its degradation by the 26S proteasome. . |
Accessions | ENST00000242719.4 Q9Y3C5 |